You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

Article metrics

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
PO.5 E- poster session 5: lupus nephritis
PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

 

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

AbstractFullPdf
Sep 202279011
Oct 2022574017
Nov 2022538019
Dec 20222504
Jan 20239908
Feb 202393017
Mar 202332013
Apr 20232005
May 20231002
Jun 2023800
Jul 20234509
Aug 20231605
Sep 20232906
Oct 20232607
Nov 20231902
Dec 20232805
Jan 20242601
Feb 2024902
Mar 20241805
Total16940138